VMMC and Safdarjung Hospital, New Delhi.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
Diabetes and Obesity are major health problems worldwide. Obesity and Diabetes are interrelated. Visceral adiposity is well correlated with insulin resistance, metabolic syndrome and cardiovascular diseases. Visceral Adiposity Index (VAI) is calculated using anthropometric and laboratory data and Visceral Fat is measured radiologically here. Following study evaluated the correlation between them.
To study correlation of visceral adiposity index with visceral fat in obese patients with and without type 2 Diabetes Mellitus.
Study Design: An observational cross sectional comparative study was conducted which included total 60 obese patients with BMI ≥ 25 kg/m2, of them 30 had type 2 diabetes mellitus (DM) and 30 were non diabetic (NDM). All were aged >40 years with no history of malignancy or any abdominal surgery.
Patients fulfilling inclusion criteria were included in the study after taking informed written consent. Physical examination and anthropometric measurements were done. Blood investigations included Lipid Profile [Total Cholesterol (TC), Serum Triglycerides (TG), High Density Lipoprotein Cholesterol (HDL), Low density Lipoprotein Cholesterol (LDL)], HBA1c, Fasting Blood Glucose (FBS) and Post-Prandial Blood Glucose (PPBS). Liver Kidney Space (LKS) measured by ultrasonography was taken as a parameter for Visceral Fat (VF). VAI was calculated using the necessary formula.
Mean VAI in DM group was 2.71±1.18 and in NDM group was 2.39±0.58. Mean VF(LKS) in DM group was 4.19±0.27 mm and in NDM group was 4.03±0.29 mm. VAI was significantly higher in females. There was significant correlation (p<0.05) of VAI with VF(LKS) in whole population, in DM group and in NDM group. No significant difference was seen in both DM and NDM in terms of VAI and VF(LKS). LKS was significantly correlated (p<0.05) with Weight, BMI, Waist circumference, FBS, TC, TG, HDL, LDL in whole population, DM and NDM group, with PPBS and HBA1c in whole population and in DM group and with height in NDM group. There was significant correlation (p<0.05) between VAI with PPBS and HBA1c in DM group.
VAI and VF(LKS) were well correlated in whole population as well as in both DM and NDM group individually but there was no significant difference between DM and NDM groups. We need large population multicentric study for better assessment and its use in clinical practise.
研究肥胖伴或不伴 2 型糖尿病患者的内脏脂肪指数与内脏脂肪的相关性。
符合纳入标准的患者在知情同意后纳入研究。进行体格检查和人体测量学测量。血液检查包括血脂谱[总胆固醇(TC)、血清甘油三酯(TG)、高密度脂蛋白胆固醇(HDL)、低密度脂蛋白胆固醇(LDL)]、糖化血红蛋白(HBA1c)、空腹血糖(FBS)和餐后血糖(PPBS)。通过超声测量肝-肾间隙(LKS)作为内脏脂肪(VF)的参数。使用必要的公式计算 VAI。
DM 组的平均 VAI 为 2.71±1.18,NDM 组为 2.39±0.58。DM 组的平均 VF(LKS)为 4.19±0.27mm,NDM 组为 4.03±0.29mm。VAI 在女性中较高。在整个人群、DM 组和 NDM 组中,VAI 与 VF(LKS)均呈显著相关性(p<0.05)。DM 和 NDM 组在 VAI 和 VF(LKS)方面无显著差异。在整个人群、DM 组和 NDM 组中,LKS 与体重、BMI、腰围、FBS、TC、TG、HDL、LDL 呈显著相关(p<0.05),与 PPBS 和 HBA1c 呈显著相关(p<0.05)在整个人群和 DM 组中,与身高呈显著相关(p<0.05)在 NDM 组中。在 DM 组中,VAI 与 PPBS 和 HBA1c 呈显著相关性(p<0.05)。
在整个人群以及 DM 和 NDM 组中,VAI 和 VF(LKS)均呈显著相关性,但 DM 和 NDM 组之间无显著差异。我们需要进行大规模的多中心研究,以更好地评估其在临床实践中的应用。